CNBX Pharmaceuticals Inc. (CNBX) stock
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
$0.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $197.79KP/E –Yield –
CNBX Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
CNBX Pharmaceuticals's price to sales ratio was 7.1× on Mar 31, 2025, against 0.9× a year earlier. Over the last 2 years it ranged from 0.0× to 163.7×, with a median of 0.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Mar 31, 2025 | 7.1× | +5.3 |
| 2024 | Dec 31, 2024 | 1.8× | +1.0 |
| 2023 | Dec 29, 2023 | 0.8× | −76.1 |
| 2022 | Dec 30, 2022 | 76.9× | – |
See a number that looks wrong?